EverEx Email Formats

IT Services and IT Consulting • 10, Gangnam-daero 94-gil, Korea, Republic of • 21-50 Employees

EverEx Email Formats

EverEx uses 3 email formats. The most common is {first name} (e.g., john@everex.co.kr), used 60% of the time.

Format	Example	Percentage
{first name}	john@everex.co.kr	60%
{first initial}	j@everex.co.kr	20%
{first initial}.{last name}	j.doe@everex.co.kr	20%

Key Contacts at EverEx

Heewon Yoon

Head Of Product, Us

Natesh Sood

Senior Director Of Client Operations

Jin Cheon

Chief Technology Officer

Company overview

Headquarters	10, Gangnam-daero 94-gil, Gangnam-gu, Seoul, 06134, KR
Phone number	+13022328483
Websites	everex.kr everex.co.kr
NAICS	5415
Keywords	Cognitive Behavioral Therapy, Pain Management, Therapeutic Exercise, Pose Estimation, dtx, Artificial Intellience
Founded	2019
Employees	21-50
Socials

About EverEx

EverEx is the leader in digital therapeutics to prevent, manage, and treat musculoskeletal disorders Founded in 2019, EverEx is a software-based therapeutics company to redefine the current standard of care for both physicians and patients through our digital therapeutics platform for musculoskeletal disorders. EverEx leverages innovative technology and clinical knowledge to improve recoveries and health outcomes of patients. Our digital therapeutics solution MORA (Mobile Orthopedic Rehabilitation Assistant) uses our own AI pose-estimation technology to empower a patient-facing mobile application for an objective and subjective evaluation of musculoskeletal conditions. For healthcare providers, we deliver a clinician-facing dashboard to track patient progress and assign an individualized curriculum from our content library of over 3000 scientific exercises developed by clinical specialists in rehabilitation, physical therapy, and cognitive behavioral therapy. We are a passionate, diverse group of medical doctors, business specialists, tech engineers, and AI scientists looking to help millions of patients with musculoskeletal conditions anywhere in their daily lives. Last but not least, we are in the process of becoming the first company to achieve the approval from the Ministry of Food and Drug Safety for musculoskeletal digital therapeutics. To learn more visit our website.